Underlying features of prostate cancer—statistics, risk factors, and emerging methods for its diagnosis

CV Berenguer, F Pereira, JS Câmara, JAM Pereira - Current Oncology, 2023 - mdpi.com
Prostate cancer (PCa) is the most frequently occurring type of malignant tumor and a leading
cause of oncological death in men. PCa is very heterogeneous in terms of grade …

Electroanalytical overview: screen-printed electrochemical sensing platforms for the detection of vital cardiac, cancer and inflammatory biomarkers

RD Crapnell, AGM Ferrari, NC Dempsey… - Sensors & …, 2022 - pubs.rsc.org
Biomarkers play an important and irrefutable role in the screening, diagnosis, monitoring
and treatment of a wide variety of human diseases. As these biomarkers inevitably feature …

Volatilomics: an emerging and promising avenue for the detection of potential prostate cancer biomarkers

CV Berenguer, F Pereira, JAM Pereira, JS Câmara - Cancers, 2022 - mdpi.com
Simple Summary The lack of highly specific and sensitive biomarkers for the early detection
of prostate cancer (PCa) is a major barrier to its management. Volatilomics emerged as a …

Molecular landscape of c-Myc signaling in prostate cancer: A roadmap to clinical translation

MA Faskhoudi, P Molaei, M Sadrkhanloo… - … -Research and Practice, 2022 - Elsevier
The c-Myc signaling is a new emerging target in cancer therapy. Activation of c-Myc
signaling leads to cancer growth and invasion in vitro and in vivo. The stability of c-Myc can …

Advancements in the diagnosis of hepatocellular carcinoma

NS Parra, HM Ross, A Khan, M Wu, R Goldberg… - International Journal of …, 2023 - mdpi.com
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy, with
increasing global incidence. Morbidity and mortality associated with HCC remains high, and …

Leptin modulated microRNA-628-5p targets Jagged-1 and inhibits prostate cancer hallmarks

L Rios-Colon, J Chijioke, S Niture, Z Afzal, Q Qi… - Scientific Reports, 2022 - nature.com
MicroRNAs (miRNAs) are single-stranded non-coding RNA molecules that play a regulatory
role in gene expression and cancer cell signaling. We previously identified miR-628-5p (miR …

Transcriptome profiling of circulating tumor cells to predict clinical outcomes in metastatic castration-resistant prostate cancer

L Groen, I Kloots, D Englert, K Seto… - International Journal of …, 2023 - mdpi.com
The clinical utility of circulating tumor cells (CTC) as a non-invasive multipurpose biomarker
is broadly recognized. The earliest methods for enriching CTCs from whole blood rely on …

Recent advances and future perspectives in the therapeutics of prostate cancer

GL Varaprasad, VK Gupta, K Prasad, E Kim… - … Hematology & Oncology, 2023 - Springer
Prostate cancer (PC) is one of the most common cancers in males and the fifth leading
reason of death. Age, ethnicity, family history, and genetic defects are major factors that …

[HTML][HTML] Liquid biopsy for prostate and bladder cancer: progress and pitfalls

L Groen, J Schalken - European urology focus, 2022 - Elsevier
Urinary liquid biopsy (LB) tests have contributed to reducing overtreatment and improving
the detection of bladder and prostate cancer. Circulating tumor cells, DNA, and RNA are the …

Aquaporins as prognostic biomarker in prostate cancer

PP Kushwaha, S Verma, S Gupta - Cancers, 2023 - mdpi.com
Simple Summary Aquaporins (AQPs) are transmembrane channel proteins that primarily
transport water across the cellular membranes. AQPs have been found to be overexpressed …